The outperformance of the nomogram indicated that combining high-throughput digital US features with Ki-67 expression could be helpful for the early individualized prediction of efficiency to NAC in breast cancer, which might provide useful information for clinical decision-making. This evidence concerns the gene MKI67 and breast cancer.